Tag Archives: INSY

Hot Casino Stocks To Own For 2019

Save and Gain (CURRENCY:SANDG) traded flat against the dollar during the 1-day period ending at 21:00 PM E.T. on August 27th. Save and Gain has a market cap of $16,051.00 and approximately $0.00 worth of Save and Gain was traded on exchanges in the last day. One Save and Gain coin can currently be purchased for $0.0052 or 0.00000079 BTC on cryptocurrency exchanges. During the last seven days, Save and Gain has traded flat against the dollar.

Here is how other cryptocurrencies have performed during the last day:

Get Save and Gain alerts:

Fusion (FSN) traded 8% higher against the dollar and now trades at $1.22 or 0.00017657 BTC. DAO.Casino (BET) traded 9% higher against the dollar and now trades at $0.0247 or 0.00000356 BTC. Manna (MANNA) traded 1.9% lower against the dollar and now trades at $0.0018 or 0.00000026 BTC. Joulecoin (XJO) traded up 1.2% against the dollar and now trades at $0.0055 or 0.00000079 BTC. Tigercoin (TGC) traded 30% higher against the dollar and now trades at $0.0030 or 0.00000044 BTC. C-Bit (XCT) traded 3.7% higher against the dollar and now trades at $0.0007 or 0.00000010 BTC. CaliphCoin (CALC) traded flat against the dollar and now trades at $0.0001 or 0.00000001 BTC. United Bitcoin (UBTC) traded 1% lower against the dollar and now trades at $3.66 or 0.00052798 BTC. BitSerial (BTE) traded 3.4% higher against the dollar and now trades at $0.0032 or 0.00000046 BTC. Super Bitcoin (SBTC) traded 1.4% lower against the dollar and now trades at $4.84 or 0.00069776 BTC.

Save and Gain Profile

Hot Casino Stocks To Own For 2019: Lakeland Industries, Inc.(LAKE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Lakeland Industries (LAKE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Lakeland Industries (LAKE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Alpine Woods Capital Investors LLC reduced its position in Lakeland Industries (NASDAQ:LAKE) by 40.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,010 shares of the medical instruments supplier’s stock after selling 10,000 shares during the quarter. Alpine Woods Capital Investors LLC owned about 0.18% of Lakeland Industries worth $194,000 at the end of the most recent quarter.

Hot Casino Stocks To Own For 2019: Cavco Industries, Inc.(CVCO)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Cavco Industries Inc  (NASDAQ:CVCO)Q3 2019 Earnings Conference CallFeb. 05, 2019, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Cavco Industries (NASDAQ:CVCO) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to

Hot Casino Stocks To Own For 2019: American States Water Company(AWR)

Advisors’ Opinion:

  • [By Neha Chamaria and Jason Hall]

    Two such amazing but little-known dividend-paying companies that our Motley Fool contributors have identified are American States Water (NYSE:AWR) and Caretrust REIT Inc. (NASDAQ:CTRE). Read along to know why you should have these stocks on your radar.

  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Reuben Gregg Brewer]

    American States Water Company (NYSE:AWR) has increased its dividend each and every year for 63 consecutive years. That’s a feat unmatched by its water utility rivals, and most other companies for that matter. But that incredible run of dividend hikes doesn’t mean that American States is a good investment. Here’s the background you need in order to make a better call here.   

  • [By Stephan Byrd]

    AWARE (CURRENCY:AWR) traded 3.3% lower against the U.S. dollar during the 24-hour period ending at 9:00 AM E.T. on June 5th. During the last week, AWARE has traded down 0.7% against the U.S. dollar. One AWARE token can now be bought for about $0.0294 or 0.00000396 BTC on major cryptocurrency exchanges including BigONE, Bibox and Allcoin. AWARE has a total market cap of $0.00 and $1.37 million worth of AWARE was traded on exchanges in the last 24 hours.

  • [By Neha Chamaria]

    In terms of dividend growth, only four of the above stocks — 3M, Colgate-Palmolive, Coca-Cola, and Procter & Gamble — feature among the 10 fastest dividend-growth kings. In other words, there are six other stocks from the dividend kings list that have grown their dividends at a faster pace than most stocks in the above table in the past decade, some even at double-digits.  

    Six top dividend kings by dividend growth

    Dividend King 10-Year Dividend CAGR Current Dividend Yield Payout Ratio (TTM)
    Lowe’s Companies  18.5% 2% 34.5%
    Hormel Foods  16.3% 2.1% 39.2%
    Parker-Hannifin Corp (NYSE:PH) 14% 1.7% 35.2%
    Nordson Corporation  12.2% 0.9% 13.3%
    Dover Corp (NYSE:DOV) 9% 2% 37.4%
    American States Water (NYSE:AWR) 7.6% 1.9% 54.8%

    TTM: Trailing 12 months. Data sources: YCharts and Yahoo! Finance. Table by author.

Hot Casino Stocks To Own For 2019: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market took a breather on Thursday, and the Dow Jones Industrial Average and S&P 500 both gave up about half a percent. Investors seemed content to accept a pause in the late-summer rally, and some pointed to ongoing fears about still-unresolved trade disputes and other global macroeconomic stresses that could become more problematic in the future. Yet even with the overall market taking a break, some stocks pushed sharply higher. Insys Therapeutics (NASDAQ:INSY), Signet Jewelers (NYSE:SIG), and Ciena (NYSE:CIEN) were among the best performers on the day. Here’s why they did so well.

  • [By Sean Williams]

    Then there are marijuana stocks that have no feel-good story whatsoever and should be just plain avoided, like drug developer Insys Therapeutics (NASDAQ:INSY).

  • [By Brian Orelli]

    Shares of INSYS Therapeutics (NASDAQ:INSY) are down 12.5% at 3:25 p.m. EDT Friday after jumping 34% higher yesterday on word that the U.S. Food and Drug Administration (FDA) had granted Fast Track designation to the company’s epinephrine nasal spray.

  • [By Keith Speights]

    Biotech

    GW Pharmaceuticals (NASDAQ:GWPH) $3.7 billion
      Cara Therapeutics (NASDAQ: CARA) $697 million
      Insys Therapeutics (NASDAQ: INSY) $473 million
      22nd Century Group (NYSEMKT: XXII) $313 million
      Corbus Pharmaceuticals (NASDAQ: CRBP) $271 million

    Ancillary provider

Top Insurance Stocks To Buy Right Now

Tim Melvin

I spend a lot of time every week scanning and searching the market (using a wide range of tools) for stocks that are unreasonably underpriced.

One of those tools that I faithfully review is the Money Morning Stock VQScoreTM. Stocks with the highest VQScore have done very well historically, and their approach finds stocks positioned for liftoff soon. And that’s just one of the tools I use every week.

This week, I ran across Tiptree Inc. (Nasdaq: TIPT) on the list of stocks with the highest VQScores. Tiptree fits most of my parameters as well so I spent a little time digging into the company further.

Tiptree is an exciting company that combines a specialty insurance operation with management’s investing experience. And this stock has the prospects for extraordinary returns for patient, aggressive investors.

Top Insurance Stocks To Buy Right Now: Ampio Pharmaceutical(AMPE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a significant increase in short interest in the month of June. As of June 29th, there was short interest totalling 14,752,101 shares, an increase of 39.8% from the June 15th total of 10,555,723 shares. Currently, 19.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,744,324 shares, the short-interest ratio is currently 8.5 days.

  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

Top Insurance Stocks To Buy Right Now: Oritani Financial Corp.(ORIT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Oritani Financial (ORIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Aperio Group LLC lifted its stake in shares of Oritani Financial Corp. (NASDAQ:ORIT) by 21.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,930 shares of the bank’s stock after acquiring an additional 9,276 shares during the quarter. Aperio Group LLC owned 0.11% of Oritani Financial worth $797,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Customers Bancorp (NYSE: CUBI) and Oritani Financial (NASDAQ:ORIT) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Top Insurance Stocks To Buy Right Now: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

  • [By Joseph Griffin]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Insys Therapeutics alerts:

    Chemotherapy Induced Nausea and Vomiting – Pipeline Insight, 2018 Market Report; Launched via MarketResearchReports.com (digitaljournal.com) Insys Therapeutics (INSY) Presents At Jefferies 2018 Global Healthcare Conference – Slideshow (seekingalpha.com) Insys Therapeutics (INSY) Expected to Announce Quarterly Sales of $27.32 Million (americanbankingnews.com) INSYS Therapeutics, Inc. (INSY)- Price to Book (P/B) Ratio in the Limelight (nasdaqfortune.com) INSYS Therapeutics to Present at Jefferies Global Healthcare Conference (globenewswire.com)

    Shares of NASDAQ:INSY traded up $0.09 during mid-day trading on Monday, reaching $6.96. The stock had a trading volume of 19,958 shares, compared to its average volume of 602,835. The company has a market capitalization of $507.07 million, a P/E ratio of -14.20 and a beta of 1.09. Insys Therapeutics has a 1 year low of $4.10 and a 1 year high of $14.00.

  • [By ]

    Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

  • [By Sean Williams]

    Yet in spite of this momentum, drug developer Insys Therapeutics (NASDAQ:INSY) has been an absolute train wreck. Insys offers a broad spectrum of therapies in its product portfolio and pipeline, but it gets its association with “marijuana stocks” through its Food and Drug Administration (FDA) approval of Syndros, a liquid dronabinol solution — i.e., a synthetic form of tetrahydrocannabinol (THC), the psychoactive component of the cannabis plant — designed to treat chemotherapy-induced nausea and vomiting, as well as anorexia associated with AIDS. It also has other cannabidiol-based products in development in its pipeline.

  • [By Brian Orelli]

    Shares of Insys Therapeutics(NASDAQ:INSY) rose 11% in June, according to data provided byS&P Global Market Intelligence. While the biotech is most famous for its opioid painkiller Subsys as well as Syndros, which is based on a compound in marijuana, it was clinical trial datafrom a new product that has investors excited.

Top 10 Safest Stocks For 2019

In a junior sector that has become quite a stock-picker’s market over the past nine months, I find some of the safest and lowest risk opportunities come when a company is undergoing a major change. Atlantic Gold (OTCPK:SPVEF) was one such idea I highlighted last year, as the company was set to transform itself into Canada’s newest junior gold producer. The stock has since moved from US$0.60 to US$1.40 and the re-rating I expect has nearly come to fruition. A company with a similar profile that I’ve had my eye on was Harte Gold (OTCPK:HRTFF), but the stock got well ahead of itself earlier this year and I exited my position. Since that time the stock has spent the last six months consolidating and finally looks it may be ready to resume the new uptrend it began earlier this year.

Top 10 Safest Stocks For 2019: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fernwood Investment Management LLC lessened its stake in VANGUARD MEGA CAP 300 GROWTH ETF (BMV:MGK) by 9.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,022 shares of the company’s stock after selling 1,698 shares during the period. VANGUARD MEGA CAP 300 GROWTH ETF comprises 1.1% of Fernwood Investment Management LLC’s portfolio, making the stock its 26th biggest holding. Fernwood Investment Management LLC owned approximately 0.06% of VANGUARD MEGA CAP 300 GROWTH ETF worth $1,911,000 as of its most recent filing with the SEC.

Top 10 Safest Stocks For 2019: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on bluebird bio (BLUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rafi Farber]

    Heres some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ:CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year byGilead Sciences Inc. (NASDAQ: GILD).

  • [By Keith Speights]

    Bellicum Pharmaceuticals (NASDAQ:BLCM) and bluebird bio (NASDAQ:BLUE) are both clinical-stage biotechs that are developing cutting-edge therapies to treat cancer and other diseases. But the fortunes of these two biotechs have been very different over the last 12 months. Bellicum stock is down 37% during the period, while Bluebird’s share price has soared more than 125%.

  • [By Todd Campbell, Leo Sun, and Daniel Miller]

    For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators’ desk for approval next year, too.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Safest Stocks For 2019: Constellium N.V.(CSTM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Constellium (CSTM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks For 2019: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.

  • [By Stephan Byrd]

    ForeScout Technologies (NASDAQ: FSCT) and Immersion (NASDAQ:IMMR) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Shane Hupp]

    Here are some of the news headlines that may have impacted Accern’s analysis:

    Get Immersion alerts:

    Turtle Beach (HEAR) and Immersion (IMMR) Are Aggressive Growth Stocks (finance.yahoo.com) Immersion (IMMR) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Is the Options Market Predicting a Spike in Immersion (IMMR) Stock? (zacks.com) Immersion (IMMR) vs. Radisys (RSYS) Head-To-Head Review (americanbankingnews.com) Stock Traders Purchase High Volume of Immersion Put Options (IMMR) (americanbankingnews.com)

    Immersion opened at $13.76 on Friday, according to Marketbeat. Immersion has a 12 month low of $13.32 and a 12 month high of $13.55. The firm has a market cap of $422.28 million, a P/E ratio of -11.56, a P/E/G ratio of 0.53 and a beta of 1.22.

Top 10 Safest Stocks For 2019: Primo Water Corporation(PRMW)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Primo Water Corp. (NASDAQ: PRMW) was started with an Outperform rating at William Blair.BMO Capital Markets maintained its Market Perform rating but the price target was raised to $16 from $15.

  • [By Andy Pai]

    Primo Water Corporation (Nasdaq: PRMW) appears to be the most undervalued stock in the fund. The company has a blended upside of 31.1 percent relative to its current trading price.

  • [By Logan Wallace]

    Primo Water (NASDAQ:PRMW) CFO David J. Mills sold 5,934 shares of the business’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $13.50, for a total value of $80,109.00. Following the completion of the transaction, the chief financial officer now owns 79,624 shares in the company, valued at approximately $1,074,924. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Top 10 Safest Stocks For 2019: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.

Top 10 Safest Stocks For 2019: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    What aboutInsys Pharmaceuticals (NASDAQ:INSY)? The biotech’s lead product is an opioid drug, but it also has an approved cannabinoid drug on the market for treatinganorexia in people with AIDS who have lost weight, and chemotherapy-induced nausea and vomiting. Insyshas a couple of experimental pain drugs in its pipeline — but none of them are cannabinoids. The company’s lead cannabinoid candidate targets childhood absence epilepsy, infantile spasms, genetic disorder Prader-Willi syndrome — but not pain.

  • [By Keith Speights]

    Insys Pharmaceuticals (NASDAQ:INSY) and Cara Therapeutics (NASDAQ:CARA) fall into the third category. However, the designations of both Insys and Cara as marijuanastocks warrant an asterisk. Insys’ cannabinoid drug Syndros is based on a synthetic form of THC, the primary psychoactive chemical in marijuana. Cara has a cannabinoid receptor agonist, CR701, in preclinical development.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

Top 10 Safest Stocks For 2019: CLP Holdings Ltd (2)

Advisors’ Opinion:

  • [By ]

    (1) Cash flow adjusted by working capital and, in the case of Aramco, $21.4 billion owed to the company from the government (2) Production for all companies is the annual average for 2016, the most recent figures available for Aramco

Top 10 Safest Stocks For 2019: EOG Resources, Inc.(EOG)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    The first quarter was an excellent one for the U.S. oil industry. Not only were crude prices at their highest level in years, but shale drillers completed gusher after gusher, enabling most to produce more oil and earnings than expected. EOG Resources (NYSE:EOG) was no different, as it joined several large peers in delivering expectation-beating first-quarter results.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.1% to $77.53, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 1.1%, at $3.16 in a 52-week range of $2.53 to $6.18. EOG Resources Inc. (NYSE: EOG) traded down about 0.2% to $109.21. The 52-week range is $81.99 to $119.00.

    In addition, the United States Natural Gas ETF (NYSEAMERICAN: UNG) traded up about 0.7%, at $222.17 in a 52-week range of $20.40 to $31.72.

  • [By Matthew DiLallo]

    Today, however, many drillers are setting a high bar for new wells. EOG Resources (NYSE:EOG) has been one of the leaders in disrupting the former way of thinking by establishing a high return hurdle rate for new wells of 30% after-tax at $40 oil. Others followed with similar return-focused approaches, including Encana (NYSE:ECA), which needs locations to achieve a 35% after-tax return at $50 oil to meet its premium hurdle rate.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 0.1%, at $81.94 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 5.7%, at $4.16 in a 52-week range of $2.53 to $5.87. EOG Resources Inc. (NYSE: EOG) traded up about 2.6% to $124.62. The 52-week range is $81.99 to $124.69 and the high was posted this morning.

    In addition, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 0.5%, at $22.84 in a 52-week range of $20.40 to $30.88.

Top 10 Safest Stocks For 2019: EQT Midstream Partners, LP(EQM)

Advisors’ Opinion:

  • [By Shane Hupp]

    SG Americas Securities LLC lowered its stake in shares of EQT Midstream Partners (NYSE:EQM) by 26.1% during the first quarter, HoldingsChannel.com reports. The firm owned 19,964 shares of the pipeline company’s stock after selling 7,067 shares during the period. SG Americas Securities LLC’s holdings in EQT Midstream Partners were worth $1,178,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on EQT Midstream Partners (EQM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    EQT Midstream Partners (NYSE:EQM) had its target price trimmed by Wells Fargo from $79.00 to $69.00 in a research report report published on Monday morning. The firm currently has an outperform rating on the pipeline company’s stock.

Top Blue Chip Stocks To Own Right Now

President Trump needs a new director for his National Economic Council after Gary Cohn resigned.

There’s one candidate in the mix that may really please investors: Chris Liddell, who has served as chief financial officer for two blue chip American companies, GM (GM) and Microsoft (MSFT)

Liddell, like the former Goldman Sachs (GS) executive Cohn, has a background in crunching numbers and dealing with Wall Street.

The New York Times first reported on Saturday that Liddell was the “top contender” to replace Cohn. A senior White House official later confirmed to CNN that Liddell is a “possibility” as a replacement for Cohn. Liddell currently serves in the White House as the director of strategic initiatives, working closely with Jared Kushner.

Ivan Feinseth, director of research and chief investment officer at Tigress Financial Partners, said he did not think an ethics complaint filed against Liddell last year because of meetings he held at the White House with executives of companies that he owned stocks in would be a major issue either.

Top Blue Chip Stocks To Own Right Now: Piedmont Office Realty Trust, Inc.(PDM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Piedmont Office Realty Trust Inc. (NYSE: PDM) dropped about 3.5% Tuesday to post a new 52-week low of $17.35. Shares closed at $17.98 on Monday and the stock’s 52-week high is $22.74. Volume was about 60% above the daily average of around 1.3 million shares. The company had no specific news.

Top Blue Chip Stocks To Own Right Now: Cheniere Energy Partners LP Holdings, LLC(CQH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cheniere Energy Partners (NYSEAMERICAN:CQH) – Equities research analysts at US Capital Advisors boosted their Q2 2018 EPS estimates for shares of Cheniere Energy Partners in a research report issued to clients and investors on Monday, May 14th. US Capital Advisors analyst J. Carreker now expects that the energy company will post earnings of $0.57 per share for the quarter, up from their prior estimate of $0.54. US Capital Advisors also issued estimates for Cheniere Energy Partners’ Q3 2018 earnings at $0.57 EPS and Q4 2018 earnings at $0.57 EPS.

  • [By Reuben Gregg Brewer]

    I wouldn’t personally buy Cheniere Energy — it has a complex corporate structure that includes not just Cheniere Energy Partners, L.P. but also Cheniere Energy Partners LP Holdings LLC (NYSE: CQH),where the only asset is an ownership stake in Cheniere Energy Partners, L.P. Cheniere Energy is attempting to resolve this issue by acquiring Cheniere Energy Partners LP Holdings. Until that process is complete, however, that’s just too much corporate complexity for my taste.

  • [By Paul Ausick]

    Cheniere Energy Inc. (NYSEAMERICAN: LNG) announced Thursday morning that it is acquiring the approximately 8.1% of subsidiary Cheniere Energy Partners Holdings LLC (NYSEAMERICAN: CQH) that it does not already own in an all-stock deal valued at $28.24 per share of Cheniere Partners Holdings.

Top Blue Chip Stocks To Own Right Now: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top Blue Chip Stocks To Own Right Now: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

  • [By ]

    Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.

  • [By Keith Speights]

    Some people picture rows of cannabis plants growing in a greenhouse when they think of marijuana stocks. While that’s an appropriate image to have in mind for many marijuana stocks, it’s a different story for others. 22nd Century Group (NYSEMKT:XXII) and Insys Pharmaceuticals (NASDAQ:INSY) are good examples.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

  • [By Sean Williams]

    Yet in spite of this momentum, drug developer Insys Therapeutics (NASDAQ:INSY) has been an absolute train wreck. Insys offers a broad spectrum of therapies in its product portfolio and pipeline, but it gets its association with “marijuana stocks” through its Food and Drug Administration (FDA) approval of Syndros, a liquid dronabinol solution — i.e., a synthetic form of tetrahydrocannabinol (THC), the psychoactive component of the cannabis plant — designed to treat chemotherapy-induced nausea and vomiting, as well as anorexia associated with AIDS. It also has other cannabidiol-based products in development in its pipeline.

Top Blue Chip Stocks To Own Right Now: Archer-Daniels-Midland Company(ADM)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is a very solid play for rocky markets and is offering a very reasonable entry point. Archer Daniels Midland Co. (NYSE: ADM) is a large agricultural services company with almost $90 billion in sales. It is in the business of converting agricultural harvest such as corn, wheat, soybeans and other products into basic ingredients for both consumer and industrial product manufacturers. Its main business lines are focused on oilseed processing, corn processing and agricultural services.

  • [By Maxx Chatsko]

    China imported 55 million gallons of American ethanol from November 2017 to the end of February 2018. It could be just the beginning. That would be great news for Archer Daniels Midland (NYSE:ADM), Green Plains (NASDAQ:GPRE), and Valero Energy (NYSE:VLO) — the three largest publicly traded ethanol producers in the United States.

Top Blue Chip Stocks To Own Right Now: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market dealt with continued volatility on Tuesday, with investors uncertain how to react to a mix of earnings and geopolitical news. Throughout most of the day, market participants were trying to predict whether the Trump administration would move forward with its plans to withdraw the U.S. from the nuclear deal with Iran, and major benchmarks stayed in a relatively tight range with a downward bias during the morning and early afternoon. After the expected announcement, the Dow fell to a triple-digit loss late in the afternoon, but it recovered by the end of the session. Adding to the gloominess was bad news regarding some key individual stocks. DISH Network (NASDAQ:DISH), Gogo (NASDAQ:GOGO), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Lisa Levin]

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 17 percent to $18.505 after the company reported a wider-than-expected loss for its first quarter.

  • [By Dan Caplinger]

    Wall Street had another good session on Tuesday, with favorable earnings reports from some of the nation’s most successful technology companies helping to lift major benchmarks by 1% or more. Investors haven’t forgotten about some of the potential pitfalls that could derail the recovery, including both geopolitical and macroeconomic concerns. Yet traders seem to want to see the market test its all-time highs before deciding whether the correction could turn into a full-fledged bear market reversal. Some individual stocks, however, missed out on the good times. GoPro (NASDAQ:GPRO), Apellis Pharmaceuticals (NASDAQ:APLS), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Lisa Levin]

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 11 percent to $19.77 after the company reported a wider-than-expected loss for its first quarter.

  • [By Paul Ausick]

    After markets closed on Monday, rental car company Hertz Global Holdings Inc. (NYSE: HTZ) and real-estate firm Zillow Group Inc. (NASDAQ: Z) reported quarterly results. Before markets opened Tuesday morning Discovery Inc. (NASDAQ: DISCA) and Dish Network Corp. (NASDAQ: DISH) also released earnings reports. Here’s a quick look at the reports and the reactions to them.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Hertz Global alerts:

    Hertz Global Holdings, Inc (HTZ) CFO Thomas C. Kennedy Buys 15,000 Shares (americanbankingnews.com) Northcoast Research Weighs in on Hertz Global Holdings, Inc’s Q2 2018 Earnings (HTZ) (americanbankingnews.com) Hertz Global Target of Unusually High Options Trading (HTZ) (americanbankingnews.com) Edited Transcript of HTZ earnings conference call or presentation 8-May-18 12:00pm GMT (finance.yahoo.com) Hertz Sweeps 2018 FlyerTalk Awards (finance.yahoo.com)

    Several equities research analysts have issued reports on HTZ shares. Zacks Investment Research upgraded Hertz Global from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Macquarie upgraded Hertz Global from a “neutral” rating to an “outperform” rating in a research report on Thursday, January 18th. Goldman Sachs dropped their target price on Hertz Global from $15.00 to $13.00 and set a “sell” rating on the stock in a research report on Thursday, February 15th. Finally, ValuEngine downgraded Hertz Global from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $15.71.

Top 10 Low Price Stocks To Watch For 2018

Want to learn how to read stock charts? 

Well, we called in Bruce Kamich, our resident Chart Professor, to help you learn that and more.

Because when it comes to investing in stocks, it is important that you are able to perform your own  technical analysis of some stock charts.

Technical analysis sounds wonky but it’s basically financial analysis that uses patterns to identify trends and make educated predictions. And that’s exactly what the Chart Professor does with his charts every day.

He walked us through four basic charts:

Line — The simplest chart because it only requires one piece of data: the stock’s last price.  So it’s basically like connect the dots but leaves out important info all-time highs, etc…. Bar — Three prices are included here: the stock’s high price, low price and its closing price of the day or week are all included in each of the individual bars line that make up this chart. Candlestick — Four prices included here: the open, the high the low and the close all make up the little rectangle shape on this chart.  relation to the open and the close — if we close below the opening — bearish and the   .  If we close above the open price, bullish  ed or pink is bearish white is bullish —  Point and Figure — The oldest chart in U.S., it dates back to 1880’s and  And a mark only is made on this chart when the stock moves a predetermined price.  In the chart in this video, each X represents a 10 points move up. A 0 notes a reaction to the move.

And then talked about the three things you need to do with each of those charts:

Top 10 Low Price Stocks To Watch For 2018: Jacobs Engineering Group Inc.(JEC)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By ]

    Jacobs Engineering (NYSE: JEC) recently closed its $3.3 billion acquisition of CH2M, which gives the firm a scale advantage in environmental cleanup and increases its capabilities across infrastructure. Jacobs is particularly strong in the aerospace and technology segment, closing multi-year awards last year for NASA and the Missile Defense Agency.

  • [By Joseph Griffin]

    Rhumbline Advisers boosted its holdings in shares of Jacobs Engineering Group (NYSE:JEC) by 1.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 191,483 shares of the construction company’s stock after purchasing an additional 2,002 shares during the quarter. Rhumbline Advisers owned about 0.14% of Jacobs Engineering Group worth $11,326,000 at the end of the most recent quarter.

Top 10 Low Price Stocks To Watch For 2018: CenturyLink, Inc.(CTL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday continued the stock market’s recent rally, with the Dow Jones Industrial Average enjoying another triple-digit gain and certain other major benchmarks starting to approach record levels. Benign news on the macroeconomic front was the latest cause for optimism among market participants, as the latest reading on inflation showed a just-right price increase that suggested a healthy economy without putting pressure on the Federal Reserve to boost interest rates too quickly. Some individual companies’ stocks saw outsize gains. Spotify Technology (NYSE:SPOT), CenturyLink (NYSE:CTL), and ARMO BioSciences (NASDAQ:ARMO) were among the best performers on the day. Here’s why they did so well.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion.
    CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion.
    Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million.
    Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million.
    IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million.
    Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million.
    Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion.
    Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion.
    ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million.
    TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion.
    Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million.
    The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million.
    Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million.
    Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million.
    tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million.
    Copa Holdings,

  • [By ]

    Likewise, the massive sums that cloud giants are spending on both AI hardware and talent, together with the huge quantities of user data they have for feeding their training systems, make it tough for smaller rivals to launch competing services. And the giant data center build-outs being carried out by public cloud service giants Amazon, Microsoft and Google make it tough for smaller rivals such as Oracle (ORCL) and CenturyLink (CTL)  — rivals that are also generally at a disadvantage in terms of the number of features they provide — to keep pace.

  • [By Travis Hoium]

    Newspaper company Gannett Co Inc (NYSE:GCI), oil giants BP plc (NYSE:BP) and Royal Dutch Shell plc (NYSE:RDS-A), and telecom company CenturyLink, Inc. (NYSE:CTL)all have unique challenges and dividends that I would never count on long-term.

  • [By Dan Caplinger]

    Telecom stocks have historically given investors a great combination of relative business stability and ample dividend income. CenturyLink (NYSE:CTL) and AT&T (NYSE:T) are two very different companies in terms of the scope and breadth of their respective businesses, but they share the common goal of trying to serve their customers with the combination of voice, data, and video services that have become their bread-and-butter offerings.

  • [By ]

    2. Century Link (NYSE: CTL)
    This communications company fits the profile of a stock being bought by insiders but lacking visible outperformance. Shares are lower by close to 30% over the last 52 weeks.

Top 10 Low Price Stocks To Watch For 2018: Mitsubishi Corporation (MSBHY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Automotive is moving well, up 14% y/y driven by HD Radio tech. The latter is included in an A list of important models, including Tesla Model 3, the Mitsubishi (OTCPK:MSBHY) Mirage and the Nissan (OTCPK:NSANY) Rogue. Their connected radio solution is also coming along nicely.

  • [By SEEKINGALPHA.COM]

    Japanese trading company Itochu (OTCPK:ITOCY) has a tough act to follow – its own meaningful improvement over the past five years. The company was more willing than most of its Japanese trading peers to deemphasize commodity/resource businesses, and it moved fairly quickly here, building up non-resource businesses like its food, machinery, and finance operations. Those moves have led to better ROE and cash flow margin performance versus its peers, and Itochu shares have done well relative to peers like Mitsui (OTCPK:MITSY), Mitsubishi (OTCPK:MSBHY), Marubeni (OTCPK:MARUY), and Sumitomo (OTCPK:SSUMY) over that time.

Top 10 Low Price Stocks To Watch For 2018: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By Logan Wallace]

    Traders sold shares of Citigroup (NYSE:C) on strength during trading hours on Friday. $105.93 million flowed into the stock on the tick-up and $172.89 million flowed out of the stock on the tick-down, for a money net flow of $66.96 million out of the stock. Of all companies tracked, Citigroup had the 0th highest net out-flow for the day. Citigroup traded up $0.29 for the day and closed at $72.86

  • [By John Maxfield]

    Maxfield: I think we mixed up some numbers. Theirrevenue as a percent of assets is4.92%, which is the highest in its peer group, and itspeer group are the really large, too-big-to-fail banks,JPMorgan Chase(NYSE: JPM), Citigroup(NYSE: C), Bank of America(NYSE: BAC), Wells Fargo(NYSE: WFC), plusother large regional banks. So that’s the largestwith one exception, and that isCapital One(NYSE: COF). The reason that Capital One’srevenue is so high as a percentage of assets is because a very largeportion of its loan portfolioconsists of credit card loans, and those yield,as everybody knows, a lot more than, say, a homemortgage does. So its revenue as a percent of assets isthe top in its peer group. But then,if you translate that over intoprofitability,that’s where that 1.1% return on assets is. When you’retalking about profitability for banks, there’stwo measures that you want to look at: yourreturn on assets andyour return on equity. Return on assets is basically yourunlevered profitability. Your return on equity is your leveredprofitability. Here’s the interesting thing about PNC, andthis is one of the reasons that it doesn’t pop up a lot wheninvestors are looking for the top-performing banks — it’s because theirreturn on common equity last year was8.58%. When you’relooking for a 10% return on equity, you think, that’sactually meaningfully below that standard industry benchmark that you want to see. But the reason that it’s below,as we see with its good return on assets,is just because it’s not very levered,which means it’s a very safe bank that’sstill earning a lot of money if you look at it on a levered basis.

  • [By Eric Volkman]

    The underwriting syndicate is large and star-studded. It is led by Morgan Stanley (NYSE: MS), JPMorgan Chase’s(NYSE:JPM)J.P. Morgan Securities, Barclays (NYSE: BCS) Capital, and Citigroup (NYSE: C) Global Markets.

  • [By ]

    Citigroup Inc. (C) , the fourth-biggest U.S. bank by assets, said first-quarter profit climbed 13% as taxes decreased following President Donald Trump’s cuts in the corporate tax rate, while stock-trading revenue jumped as market volatility rebounded following a sluggish 2017. 

Top 10 Low Price Stocks To Watch For 2018: NewMarket Corporation(NEU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NewMarket (NEU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Watch For 2018: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Top 10 Low Price Stocks To Watch For 2018: CryoLife, Inc.(CRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CryoLife (NYSE:CRY) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.29-0.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.31. The company issued revenue guidance of $250-256 million, compared to the consensus revenue estimate of $252.86 million.

Top 10 Low Price Stocks To Watch For 2018: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Watch For 2018: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Insys Therapeutics (INSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Some people picture rows of cannabis plants growing in a greenhouse when they think of marijuana stocks. While that’s an appropriate image to have in mind for many marijuana stocks, it’s a different story for others. 22nd Century Group (NYSEMKT:XXII) and Insys Pharmaceuticals (NASDAQ:INSY) are good examples.

  • [By ]

    Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.

Top 10 Low Price Stocks To Watch For 2018: NF Energy Saving Corporation(NFEC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st